Results 11 to 20 of about 8,421 (225)
Non-vitamin K antagonist oral anticoagulants (novel oral anticoagulants, NOACs) are important pharmaceuticals for prevention of stroke and systemic embolism in non-valvular atrial fibrillation patients.
Larysa A. Vozniuk+2 more
doaj +1 more source
Management of haemorrhage in patients receiving non-vitamin-k oral anticoagulants treatment: Case report [PDF]
Introduction: Management of haemorrhage depends on the severity of bleeding and associated injuries. In this paper, we present a case of bleeding patient on the anticoagulants for which there was no specific reversal agent. Aim of the study is to present
Rangelov-Kulezić Jasmina+3 more
doaj +1 more source
Treatment of Permethrin Toxicosis in Cats by Intravenous Lipid Emulsion
Background: In this study, the clinical response to treatment with intravenous lipid emulsion (ILE) for nine cats intoxicated with permethrin has been described.
Simona Di Pietro+5 more
doaj +1 more source
Synthetic Amphoteric Cryogels as an Antidote against Acute Heavy Metal Poisoning
The effectiveness of an amphoteric cryogel (AAC) as an oral sorbent (enerosorbent) for the treatment of acute poisoning of small animals (rats) with heavy metals (HMs) was studied in in vivo experiments.
Alzhan Z. Baimenov+6 more
doaj +1 more source
Background and Objectives: Thrombolytic therapy with recombinant tissue-type plasminogen activator (rt-PA) is used to treat acute ischemic stroke. Dabigatran is a reversible thrombin inhibitor approved for stroke prevention in patients with nonvalvular ...
Ilga Kikule+3 more
doaj +1 more source
Anticoagulants: dose control methods and inhibitors
These days, anticoagulants are in great demand. They are used as a prophylaxis for thromboembolic complications in various diseases and conditions in general therapeutic practice, cardiology, neurology, as well as obstetrics to manage high-risk ...
V. O. Bitsadze+9 more
doaj +1 more source
Optimization of a nicotine degrading enzyme for potential use in treatment of nicotine addiction
Background Smoking and tobacco use continue to be the largest preventable causes of death globally. A novel therapeutic approach has recently been proposed: administration of an enzyme that degrades nicotine, the main addictive component of tobacco ...
Thomas Thisted+9 more
doaj +1 more source
Background The bacterial nicotine-degrading enzyme NicA2 isolated from P. putida was studied to assess its potential use in the treatment of tobacco dependence. Results Rats were pretreated with varying i.v.
Paul R. Pentel+6 more
doaj +1 more source
Protective effects and therapeutic applications of ellagic acid against natural and synthetic toxicants: A review article [PDF]
Traditional herbal drugs are widely used for the treatment of various diseases. Ellagic acid (EA) as an herbal polyphenol metabolite exists in many medicinal plants.
Karim Naraki+2 more
doaj +1 more source
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Hepatology, EarlyView.
Robert J. Fontana+6 more
wiley +1 more source